Palliative care in castrate-resistant prostate cancer - Abstract

Significant symptoms and suffering related to castrate-resistant prostate cancer (CRPC) are associated with the disease and its treatment.

Increasingly, with advances in treatment efficacy, men can live with symptoms for long periods. Interdisciplinary palliative care teams (including physicians, nurses, social workers, chaplains, pharmacists, psychologists, physical therapists, and nutritionists) focused on symptom management and patients' goals of care can collaborate with prostate cancer surgeons, oncologists, and radiation oncologists to provide the best care for men at all stages of treatment, including end of life. This article reviews the benefits of palliative care in helping patients with CRPC manage symptoms and distress.

Written by:
Rabow MW, Lee MX.   Are you the author?
Symptom Management Service, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, Suite 313, 1545 Divisadero Street, San Francisco, CA 94143-0320, USA.

Reference: Urol Clin North Am. 2012 Nov;39(4):491-503.
doi: 10.1016/j.ucl.2012.07.006


PubMed Abstract
PMID: 23084526

UroToday.com Prostate Cancer Section